Sign in now to see personalised content appear here.

You can also see your reading history and subscription details on your subscriber page.

Why subscribe?
Find out more.

Sign up for your FREE email newsletter  +


Medical breakthroughs on the horizon with a UK research boost of £32m

Since 2011 there has been a total investment of £350m, split equally between the MRC, Innovate UK and leveraged funding from industry

Europe | R and D | Finance

Recipharm and Adroit Science collaborate and expand service offering

Solid-state characterisation services will enhance complete molecule-to-product development capability

Measurement and Analysis

Quantitative Western blotting for monitoring biopharma production

Western blotting methods have changed little in 30 years. But this technique has traditionally been restricted by issues of variability. Mats Falk, GE Healthcare Life Sciences, argues that new technologies and detection techniques herald a new era

Biotechnology | Measurement and Analysis

Manufacturers to get more support from UK government

The UK government has announced the latest winners from a fund to help rebuild British manufacturing prowess

Europe | Finance

German pharmaceutical market value to reach US$65bn by 2020

Cost saving government policies will be the greatest barrier to future growth

Europe | Finance

Designing optimised, site-specific ADCs

Antibody-drug conjugates have provided a breakthrough in targeted medicines but ways of increasing their stability and efficacy are still required. Catalent highlights how these goals can be achieved using its SMARTag technology platform to produce site-specific ADCs

R and D

Capsugel to invest more than US$25m in capacity and quality enhancements for vegetarian capsule portfolio

Will include new production lines and technology upgrades at four facilities worldwide

North America | Drug Delivery

Navigating supply chains in a tightly regulated world

To meet changing business models and complex regulation, Diane Palmquist, VP, Manufacturing Industry Solutions at GT Nexus argues that supply chain visibility has to see fundamental change too

Information Technology

Ablynx extends ion channel research collaboration with Merck & Co

Merck & Co will fund the research until 30 September next year

Europe | R and D

Alzheimer’s drug development: Time for a regulatory rethink?

At a recent EMA workshop held in London to discuss the lack of progress on Alzheimer’s therapies, drug developers highlighted the hurdles faced in meeting standards for drug approval

Europe | Regulatory | R and D | Therapeutic Sector

Green Cross and Nanolek agree partnership for biologics commercialisation in Russia

Nanolek will license the technology and manufacture a number of biologics for Green Cross

Europe | Biotechnology | Asia

Focus turns to pre-empting disease causes and ageing

Drug discovery is brimming with innovation and technology but success is still seldom and slow. Susan Birks reports on the changing discovery landscape and how the odds can be improved

R and D | Biotechnology